Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 22 | 22 | 0 |
| Shares | 1.18M | 1.23M | +48.4K (+4.1%) |
| Value | $4.81M | $3.82M | −$986.0K (−20.5%) |
New holders (5)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 74,060 | $230.0K | 0.00% |
| Millennium Management LLC | 24,134 | $75.0K | 0.00% |
| Two Sigma Securities, LLC | 11,161 | $35.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 698 | $2.00K | 0.00% |
| Federated Hermes, Inc. | 164 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| ACT Capital Management, LLC | 25,000 | $102.0K |
| HRT Financial LP | 11,879 | $48.0K |
| Rockefeller Capital Management L.P. | 5,500 | $22.0K |
| Professional Financial Advisors, LLC | 500 | $2.00K |
| Harbour Investments, Inc. | 241 | $1.00K |